Stockscreener 앱 받기
160.03
1.26%
1.99
시간 외 거래:
160.00
-0.03
-0.02%
Illumina Inc 주식(ILMN)의 최신 뉴스
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN): Bullish Structure Builds After Breakout - FXEmpire
Illumina SVP Patricia Leckman sells $127,304 in company stock - Investing.com
Illumina (ILMN) Chief People Officer sells 783 common shares - Stock Titan
Illumina Inc. stock (US4523271090): new StrataMap launch after strong 12?month rally - AD HOC NEWS
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
8 Cancer organizations receive grants to expand access to genomic testing - Illumina
Illumina Launches StrataMap Spatial Solution for Whole Transcriptome Analysis - geneonline.com
Illumina launches StrataMap Spatial research solution By Investing.com - Investing.com Canada
Illumina launches StrataMap Spatial research solution - Investing.com
Illumina Launches StrataMap Spatial Solution, a Powerful End-to-end Spatial Whole Transcriptome Research Solution - 富途牛牛
Why Grail Could Be the Sleeper Stock Everyone's About to Notice - The Motley Fool
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina (Nasdaq: ILMN) Form 144 lists proposed sale by trust - Stock Titan
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) chief people officer sells 784 shares in open market - Stock Titan
What is multiomics? A simple guide to the future of biology - Illumina
Loomis Sayles Growth Portfolio's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc. stock (US4523271090): shares edge higher on Nasdaq amid focus on sequencing demand and - AD HOC NEWS
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina jumps as bullish analyst note extends optimism around clinical sequencing momentum - Quiver Quantitative
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? - TradingView
IDT and Illumina Streamline Oncology Sequencing Analysis - Technology Networks
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina, Inc. Hits New 52-Week High of $165.93, Up 54% - Markets Mojo
Illumina, Inc. Hits New 52-Week High at USD 165.37 - Markets Mojo
Illumina, Inc. Hits New 52-Week High of $158.78, Up 48.7% - Markets Mojo
[144] ILLUMINA, INC. SEC Filing - Stock Titan
Frances Arnold reports proposed sale of 5,000 shares | ILMN SEC FilingForm 144 - Stock Titan
IDT partners with Illumina on oncology research workflow - Investing.com UK
Illumina Insider Sold Shares Worth $107,042,631, According to a Recent SEC Filing - Moomoo
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - BioSpace
Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN) - GuruFocus
Why (ILMN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Illumina director Keith Meister sells $107 million in shares By Investing.com - Investing.com Australia
Illumina director Keith Meister sells $107 million in shares - Investing.com
Illumina(ILMN.US) Director Sells US$107.04 Million in Common Stock - Moomoo
Corvex funds tied to Illumina (ILMN) log 669,596-share stock sale - Stock Titan
Illumina VP, chief accounting officer sells $305,150 in ILMN stock By Investing.com - Investing.com Australia
Guggenheim raises Illumina stock price target on clinical market strength - Investing.com UK
Illumina VP, chief accounting officer sells $305,150 in ILMN stock - Investing.com
Illumina (ILMN) legal chief sells 615 shares in open market trade - Stock Titan
Illumina Inc. stock (US4523271090): New oncology research workflows and MRD solution highlight innov - AD HOC NEWS
Illumina (ILMN) chief accounting officer sells 2,000 company shares in open market - Stock Titan
Hunting for hidden clues in the human genome’s “dark regions” - Illumina
Integrated DNA Technologies (DHR) Partners with Illumina for Enh - GuruFocus
IDT partners with Illumina on oncology research workflow By Investing.com - Investing.com South Africa
Guggenheim Maintains Illumina(ILMN.US) With Buy Rating, Raises Target Price to $180 - Moomoo
Guggenheim raises Illumina stock price target on clinical market strength By Investing.com - Investing.com Australia
Illumina, Inc. (ILMN) Stock Analysis: Understanding the Growth Potential Amidst a Robust Market Cap - DirectorsTalk Interviews
Illumina Inc. stock (US4523271090): shares track Nasdaq ahead of next catalysts - AD HOC NEWS
Here's why Illumina (ILMN) is a strong momentum stock - MSN
Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance Singapore
Illumina Inc. stock (US4523271090): insider share sale and new MRD kit draw investor focus - AD HOC NEWS
Why Illumina (ILMN) is a top momentum stock for the long term - MSN
Illumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360
Corvex Management LP sells multiple ILMN blocks (ILMN) in May 2026 - Stock Titan
lllumina Beats Rival’s DNA-Sequencing Tool Monopolization Claims - news.bloombergtax.com
Illumina, Inc. Hits Day High with Strong 5.68% Intraday Surge - Markets Mojo
Illumina (NASDAQ: ILMN) director sold 1,500 shares under 10b5-1 plan - Stock Titan
2.10%
자본화:
|
볼륨(24시간):